Daré Bioscience, Inc. (NASDAQ:DARE) Q3 2023 Earnings Call Transcript

Operator: Welcome to the conference hosted by Daré Bioscience to Review the Company's Third Quarter Financial Results and to provide a General Business Update. This call is being recorded.

Related Keywords

United States ,Catherine Novack ,Sabrina Martucci Johnson ,Lisa Walters Hoffert ,Nasdaq ,Clinical Trials Network ,National Institute Of Child Health ,Dare Bioscience Inc ,Human Development ,Bioscience Inc ,Call Transcript November ,Third Quarter Financial Results ,General Business ,Chief Executive Officer ,John Fair ,Chief Commercial Officer ,Chief Financial ,Martucci Johnson ,Safe Harbor ,Private Securities Litigation Reform Act ,Investor Relations ,Sildenafil Cream ,Then John ,National Institute ,Child Health ,Sildenafil Cream Phase ,Risk Factors ,Beauty Stocks To Buy Now ,Best Dog Foods ,Dare Bioscience ,